Determination of propranolol chloride content in generic, similar and manipulated medicinal product by ultraviolet-visible spectrophotometry
Propranolol Hydrochloride inhibits the stimulation of beta-adrenergic receptors (beta-1 and beta-2) present in the body such as the heart and blood vessels. It was the first successful beta-blocker developed, it is one of the most used drugs mainly in the treatment of hypertension, it is also indicated for the treatment and prevention of myocardial infarction, angina, cardiac arrhythmias, as well as migraine. However, this article aims to verify the Propranolol Hydrochloride content in Generic, Similar and Manipulated drug, by ultraviolet-visible spectrophotometry.